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Available online 9 July 2016Multiparticulate formulations are composed ofmultiple solid dosage units which can be administered directly to
the mouth or sprinkled on food. Oral grittiness (i.e. roughmouthfeel) may arise from the presence of particles in
the mouth, limiting palatability. In this work, multiparticulate formulations were prepared by dispersion of
spherical granules into orange ﬂavoured vehicles thickened with hypromellose (HPMC) at different viscosities
in order to assess oral perception of grittiness by a panel of thirty adults through direct scaling on a 100mmvisual
analogue scale. The effect of formulation factors such as particle size (90, 127, 263 μm), amount of particles per
10 ml (0.25, 0.50, 1.00 g) and viscosity of the vehicle (0.08, 0.43, 2.80 Pas) were investigated. Grittiness was in-
creasingly perceived with increasing amount and size of particles. Increasing viscosity of the administration
media had a masking effect on the perception of particles. Less gritty samples were generally regarded as
‘more pleasant’ by the participants of the study. However, samples dispersed in thickened vehicles seemed to
be less preferred despite being less gritty; which could be ascribed to an unpleasant mouthfeel of the vehicle.
In thedesign ofmultiparticulate formulations acceptable for a targetedpatient group all these formulation factors
will need to be considered and optimised.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Multiparticulate formulations1. Introduction
Multiparticulate drug delivery systems are composed of multiple
solid dosage units, such as granules, pellets or minitablets, which are
ﬁlled in a suitable primary packaging system (e.g. capsules or sachets).
A popular technology for the preparation of these systems is active
layering, whereby a drug solution or suspension is sprayed onto inert
pellets (cores or seeds) by ﬂuidised bed coating (Priese et al., 2014).
Inert seeds made of sugar, microcrystalline cellulose or starch (among
other materials) are commercially available for this purpose. Alterna-
tively, the drug can be incorporated into the starter cores during the
pelletisation process, followed by one or multiple layers of ﬁlm coating
(Priese et al., 2014). Based on the physicochemical properties of the
drug and the targeted release proﬁle many variations of the
manufacturing process have been investigated (Abbaspour et al.,
2014; Ahmad et al., 2014; Maniruzzaman et al., 2012; Otero-Espinar
et al., 2010; Priese et al., 2014; Zolkefpeli and Wong, 2013). Recently,
multiparticulates have attracted a great deal of attention for the prepa-
ration of medicines suitable for paediatrics as they offer a range of ad-
vantages for the delivery of drugs to these patients. These include
improved ease of swallowing and ﬂexible dose titration compared tor B.V. This is an open access articlconventional tablets and capsules, suitability for taste masking, con-
trolled drug release and multiple drug delivery in the form of ﬁxed
dose combinations (Desai et al., 2013; Lopez et al., 2015). In addition,
other patient populations with similar needs such as older patients
could also beneﬁt from this drug delivery approach.
Despite the fact that multiparticulates have been used for some time
and now thought to ease administration of medicines in children, little
is known about their acceptability and patient preferences.
Multiparticulates can be reconstituted in a suitable drink to provide a
suspension or added onto soft food as a sprinkle for ease of
administration. Alternatively, vehicles for the oral administration of
multiparticulates could be designed, manufactured and supplied to pa-
tients for a more standardised administration (Kluk and Sznitowska,
2014). The administration vehicle is expected to have a great inﬂuence
on the overall patient experience by affecting various parameters such
as the rate of sedimentation of the dispersed particles and the percep-
tion of particles in the oral cavity upon ingestion. In this regard, the vis-
cosity of the vehicle could be adjusted appropriately in order to hinder
sedimentation hence improving dose uniformity and, potentially, re-
ducing perception of particles in the mouth (Kluk and Sznitowska,
2014). The reconstituted product could then be easily administered to
paediatric patients with the aid of a suitable dosing device, such as a
measuring spoon. Nevertheless, in the instance of co-administration
with food or other vehicles the potential impact of this practice on thee under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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et al., 2014).
Palatability is a critical parameter of oral formulations and especially
those intended for paediatric patients. Poor palatability is likely to be
linked to reduced patient compliance to a therapeutic regime, which
will have a detrimental effect on the outcomes of the drug therapy
(Baguley et al., 2012; Mennella et al., 2015). The current regulatory
framework for development of medicines for paediatric use advise of
the need for evaluating palatability and acceptability, deﬁned as the
overall ability and willingness of the patient to use a medicinal product
as intended (European Medicines Agency, 2013). However, there is no
ofﬁcial guidance for the assessment of palatability and acceptability of
oral dosage forms. Most of the work that has been conducted is based
on the utilisation of visual analogue scales (VAS) (van Riet-Nales et al.,
2013). Taste is often considered themost important factor affecting pal-
atability of oral medicines. In the case of multiparticulate drug delivery
systems, an unpleasant (usually bitter) taste of the active pharmaceuti-
cal ingredient (API) could be overcome by application of a polymeric
coating around the drug-loaded granules (Stange et al., 2014). There-
fore, taste of the API would likely become less of an issue whereas oral
grittiness (i.e. a rough feeling in the mouth) could turn out to be the
major determinant of palatability and acceptability of the formulation.
Grittiness and poor mouthfeel due to the presence of particles in sus-
pension have been reported as a likely constraint in the administration
of multiparticulates (Liu et al., 2014). However, the relationship be-
tween different formulation variables and the perception of oral gritti-
ness has not been established yet.
In this study, perception of oral grittiness from placebo
multiparticulate formulations was evaluated by a panel of healthy
adult participants. For the purpose of this study, it was assumed that
multiparticulate formulations would be prepared as a solid product
ﬁlled into a suitable primary packaging system (e.g. sachets) which
can be opened by the patient to disperse the contents in a vehicle
prior to administration. Multiparticulate formulations were prepared
using commercially available granules of different particle size in nar-
row size ranges. Variable amounts of these particles were dispersed in
orange ﬂavoured oral hydrogels (containing HPMC as viscosity modiﬁ-
er) and administered to the participants of the study with a suitable
spoon. The aim was to determine the effect of particle size, quantity of
particles and viscosity of the suspending media on perception of oral
grittiness and patient preferences of multiparticulate formulations.2. Materials and methods
2.1. Materials
Hydroxypropyl methylcellulose (HPMC, hypromellose) (4000 cP,
substitution type 2906, grade 65SH-4000) was obtained from Shin-
Etsu Chemical Company Ltd. (Tokyo, Japan). Microcrystalline cellulose
spheres (Cellets®, type Cellets 90, Cellets 127, Cellets 263 and Cellets
500) were kindly provided by Pharmatrans Sanaq (Basel, Switzerland).
Details of the particles are provided in Table 1. Orange FlavourGivarome
Permaseal and Orange Flavour Permaseal were received from Givaudan
(Vernier, Switzerland). Sucralose Granular NF (Emprove, NF) was pur-
chased from Merck KGaA (Darmstadt, Germany).Table 1
Particle size descriptors of Cellets (≥85% of particles within given
range).
Commercial ID Size range (μm)
Cellets 90 63–125
Cellets 127 100–160
Cellets 263 212–300
Cellets 500 500–7102.2. Physical characterisation of multiparticulates
Themorphological features of the particles were imaged using Scan-
ning Electron Microscopy (SEM). Samples were adhered onto alumini-
um stubs (TAAB Laboratories, Reading, U.K.), sputter coated with gold
under vacuum and then imaged at different magniﬁcation levels using
a Quanta 200F instrument (FEI, Hillsborough, OR, USA). Images were
collected before and after dispersion of Cellets in deionised water for
24 h to assess the effect of water on particle morphology (wet samples
were ﬁltered and oven dried at 30 °C for 4 h before imaging). The aspect
ratio of the particles was calculated as dmin/dmax (where dmax is the
major diameter and dmin is the minor diameter) and the circularity fac-
torwas calculated as 4πA/P2 (where A is the area and P is the perimeter)
using ImageJ software (National Institutes of Health, Bethesda, MD,
USA).
The particle size distribution of the granules was assessed by laser
diffraction using a Mastersizer 3000 ﬁtted to an Aero S and a Hydro
MV feeding systems for dry and wet dispersion, respectively (Malvern
Scientiﬁc, Worcestershire, UK). The air pressure and feeding rate were
optimised to allow dry dispersion of the particles.Wet dispersionmeth-
od was carried out using deionised water as dispersant; samples were
pre-dispersed in deionised water for nearly 60 min before analysis to
allow water sorption equilibrium. Six replicates of each sample were
tested.
2.3. Preparation and rheological assessment of suspending media
HPMC aqueous vehicles were prepared by addition of HPMC (0.5%,
1.0% or 2.0% w/w) to 100ml of distilled water under continuous stirring
at 80–100 °C followed by a rapid cool down on ice to form the gel struc-
ture. HPMC vehicles were sweetened with 0.10% (w/v) of sucralose and
ﬂavouredwith 0.4–0.5% (w/v) orange ﬂavour. Sampleswere autoclaved
at 121 °C for 20 min and then stored in closed containers at room tem-
perature for 24 h before viscometry and sensory evaluation. A Bohlin
Gemini HR rotational rheometer system (Malvern Instruments Ltd.,
Malvern, UK) was used to investigate the rheological properties of the
samples using a cone and plate geometry (55 mm diameter, 2° angle).
A 2ml sample approximatelymeasuredwith a plastic spoonwas placed
onto the plate, the gap width was adjusted to 200 μm and the sample
excess was removed. Samples rested for 180 s before each measure-
ment to minimise the effect of sample shear history. A ‘shear sweep’
measurement mode was used whereby the shear rate of the sample is
controlled by the rheometer and advanced in increments across the de-
sired range (0.9–200 s−1). This procedure was repeated three times for
each sample. Throughout testing the temperature of the sample was
maintained at 25 °C. The range of shear rates was chosen to represent
the ﬂow conditions experienced by the sample in practice, frommanip-
ulation in the spoon to swallowing (O'Leary et al., 2010). However, a
shear rate of 50 s−1, often taken as a representative shear rate of the
mouth cavity, was used as a benchmark to compare samples
(Zargaraan et al., 2013).
2.4. Oral sensory evaluation of multiparticulate formulations
2.4.1. Experimental design and sample preparation
Samples for oral sensory evaluation were composed of 10 ml of
sweetened, orange ﬂavoured HPMC oral gels in which Cellets were dis-
persed by automated inversion (32 rpm). Homogeneous dispersion of
particles in the media was conﬁrmed by visual inspection immediately
before sensory evaluation.
In the study of oral grittiness perception of placebo multiparticulate
formulations three different variables were considered: amount of par-
ticles per sample, particle size and concentration of HPMC in the oral ve-
hicle. A three-factor, three-level full factorial design was conducted, as
shown in Fig. 1. All possible combinations of each factorwere investigat-
ed, resulting in a total of 27 samples (3 particle sizes × 3 amounts of
Fig. 1. Experimental design space: all possible combinations of three factors (amount of
particles, particle size and concentration of HPMC) at three different levels (0.25, 0.50,
1.00 g; 90, 127, 263 μm; 0.5, 1.0, 2.0% w/v; respectively) were investigated.
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consisting of 0.5% (w/v) HPMC without particles and a positive control
consisting of 0.5% (w/v) HPMC with 1 g of Cellets 500 were prepared
and evaluated.
2.4.2. Measurement of oral grittiness in adult volunteers
Thirty young adults aged between 20 and 25 years old (median 23;
14 men and 16 women) were enrolled in a randomised single-blind
study. Participants were recruited by internal advertising at The School
of Pharmacy, University of London, and included university staff and
students. All participants provided written consent to participate in
the study. The study was conducted in accordance with the Declaration
of Helsinki and its amendments, and the protocol was approved by the
Research Ethics Committee at The School of Pharmacy, University of
London (REC/A/09/01). The sensory evaluationwas carried out in a des-
ignated roomat The School of Pharmacy free fromany distractingnoises
or smells. The study was conducted over two sessions, taking place on
separate days to minimise participants discomfort and fatigue. At the
start of each session, participants were presented with non-blinded
negative and positive controls as references for samples to be consid-
ered “least gritty” and “most gritty” respectively. Thereafter, partici-
pants received the blinded samples (labelled with a randomised 3-
digit code) in an individually randomised order. Each participant tested
27 samples in between the two session plus blinded negative and posi-
tive controls which were also given in a randomised order during the
course of the sensory evaluation.
Samples were evaluated following a ‘swirl and spit’methodology by
which participants placed each 10ml sample in their mouth, keeping it
moving for about 15 s before spitting it out. Sampleswere administered
with a ﬂat bottom plastic dosing spoon with sufﬁcient capacity for
10 ml. Immediately upon expectoration of the sample participants
rated the intensity of the test stimuli on paper-based questionnaires
with a bipolar 100 mm visual analogue scale (VAS) labelled from
“very smooth” to “very gritty” on the left and right ends, respectively.
Participants had free access to water and rinsed their mouth before
and after each sample. After testing all the samples on each session, par-
ticipants were asked to rate the “two most pleasant formulations” in
order to evaluate their formulation preferences.
2.5. Statistical analysis of the data
The measurement on the VAS scale in mm (where very smooth is
0 mm and very gritty is 100 mm) was used for data processing. Dataobtained was expressed as mean ± standard deviation (n = 30). The
factor delta (δ) was calculated as the difference between the maximum
and minimum mean response across levels of a factor. Box plots were
produced for visual interpretation of the data, where centre lines repre-
sent the median, box limits indicate the 25th and 75th percentiles,
whiskers extend 1.5 times the interquartile range, and outliers are rep-
resented by dots.
Differences between genders and between both sessions of the
study were evaluated by Mann-Whitney U test using the blinded con-
trols (as these were assessed on both days). Then, data from both ses-
sions was combined and statistical analysis was performed using
Kruskal-Wallis one-way analysis of variance followed by Xin Gao's test
as post-hoc analysis (Gao et al., 2008).
The obtained responses for each factor level combinationwere ﬁtted
to amodel bymultiple lineal regression analysis. Themodelwas simpli-
ﬁed by a stepwise process and insigniﬁcant terms (p N 0.01) were re-
moved from the model equations. The model was validated by one-
way analysis of variance (ANOVA) and lack of ﬁt test. Simpliﬁedmodels
were used tomap out the inﬂuences of independent variables on the re-
sponse via 2-D contour plot analyses.
The number of times each formulation was selected as “most pleas-
ant” was recorded. A ‘sample preference’ factor was calculated as the
percentage of participants who selected each sample as one of the two
most pleasant. Non-parametric association between grittiness VAS
score and sample preferencewasmeasuredby Spearman's rank correla-
tion coefﬁcient.
Data analysis was performed using Minitab 17 software (version
17.2.1, Minitab Inc., Pennsylvania, U.S.A.) and R software (open source).3. Results
3.1. Physical characterisation of the particles
SEM images of Cellets revealed their spherical morphology and
smooth surface as shown in Fig. 2. Average particle circularity was de-
termined to be ≥0.85 and the aspect ratio ≥ 0.90 for all particle size frac-
tions. As the values approach 1 the sphericalmorphology of theparticles
was conﬁrmed. Cellets retained their spherical shapewhen dispersed in
an aqueous environment for up to 24 h and no signiﬁcant disintegration
of the particles occurred. The suitability of Cellets for dispersion in an
aqueous vehicle prior to administration was thus conﬁrmed.
All samples exhibited a narrow, symmetric, unimodal particle size
distribution, as shown in Fig. 2. When assessed by dry dispersion meth-
od, the median particle size of Cellets 90, 127, 263 and 500 was ca. 90,
128, 263 and 605 μm, respectively. When Cellets were dispersed in
water a subtle increase in particle size was found, which was attributed
to water sorption and moderate swelling of the particles. The median
particle size of Cellets shifted to ca. 99, 141, 285 and 620, respectively;
that is around 10% increase with respect to their original size.3.2. Rheological properties of the suspending media
The HPMC aqueous gels used as media for oral administration
showed shear thinning behaviour, this means that the apparent viscos-
ity of the sample decreased as the shear rate was increased (Fig. 3). The
viscosity of the aqueous gels increased with increasing HPMC concen-
tration, as expected. The vehicle containing 0.5% HPMC showed an ap-
parent viscosity of 0.08 ± 0.01 Pas, the 1.0% HPMC vehicle showed an
apparent viscosity of 0.43 ± 0.06 Pas and the 2.0% HPMC vehicle
showed and apparent viscosity of 2.80 ± 0.04 Pas, measured at a
shear rate of 50 s−1. The consistency of the three vehicles prepared
could be classiﬁed as nectar-thick (51–350 mPas), honey-thick (351–
1750 mPas) and spoon thick (N1750 mPas), respectively, according to
the National Dysphagia Diet (NDD) guidelines (Zargaraan et al., 2013).
Fig. 2. SEM images of (a) dry and (b) wet Cellets 500 at 100× and 500× (inlet) magniﬁcation; and (c) particle size distribution of Cellets assessed by laser diffraction using dry dispersion
and wet dispersion methods.
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The results obtained in the trial are presented in Fig. 4. Average grit-
tiness VAS scoreswere below60 for all samples testedwith exception of
the positive control (the median grittiness VAS score was 24.6). Gritti-
ness VAS scores tended to be higher with increasing particle size and
also with increasing amount of particles. On the contrary, grittiness
VAS scores tended to be lower with increasing HPMC content in the ve-
hicle (i.e. with increasing viscosity of the suspending media). In agree-
ment to this trend, the sample with the highest grittiness VAS score
(57 ± 24, disregarding the positive control) contained the highest
level of particle size (263 μm)and amount of particles (1.00 g) dispersed
in the vehicle of lowest viscosity (0.5% HPMC); whereas the sample
with the lowest grittiness VAS score (12 ± 15) contained the smallest
particles (90 μm) at the lowest amount (0.25 g) dispersed in the vehicle
of highest viscosity (2.0% HPMC). No signiﬁcant differences in grittinessFig. 3. Shear sweep measurements of autoclaved, ﬂavoured and sweetened HPMC
suspending media showing apparent viscosity of samples over a range of shear rates.perceptionwere found betweenmen andwomen and no signiﬁcant dif-
ferences were found between both sessions of the study.
The blinded positive control containing 1.00 g of particleswith ame-
dian particle size ca. 605 μm scored an average grittiness VAS score of
87 ± 12, whereas the blinded negative control (no particles) scored
an average grittiness VAS score of 1.6 ± 2.3. As it can be expected,
these were the two most extreme values recorded during the study,
which conﬁrms their appropriateness as positive and negative controls,
respectively.
3.3.1. Effect of particle size on oral grittiness perception
Oral grittiness perception increased with increasing particle size.
Particles of 90 μm scored an average VAS score of 22 ± 9, compared toFig. 4. VAS scores of oral grittiness for samples containing 90, 127 and 263 μm particles
(P_SIZE), in amounts of 0.25, 0.50 and 1.00 g (AMOUNT), dispersed in 10 ml of orange
ﬂavoured oral gels with HPMC at a concentration of 0.5, 1.0 and 2.0% w/w
(HPMC_CONC); administered with a spoon to young adults. The dotted lines represent
the population median VAS score as a reference.
160 F.L. Lopez et al. / European Journal of Pharmaceutical Sciences 92 (2016) 156–16226± 8 scored by particles of 127 μm and 38± 12 scored by particles of
263 μm (δ= 16). However, all these samples scored an average gritti-
ness VAS score below 50, which indicates low perception of grittiness
regardless of the particle size in the range of 90–263 μm. In contrast,
samples containing particles of 605 μm (positive control) scored a
much higher grittiness VAS score on average (87 ± 12, when given as
a blinded sample).
3.3.2. Effect of amount of particles on oral grittiness perception
Three different amounts of particles were evaluated, 0.25, 0.50 and
1.00 g of particles in 10ml samples, which correspond to concentrations
of 125, 250 and 500 mg/5 ml, respectively. The amount of particles per
samplewas a signiﬁcant driver of theperception of grittiness. As expect-
ed, grittiness perception increased as the amount of particles in the
sample increased. Samples containing 0.25, 0.50 and 1.00 g of granules
scored an average VAS score of 19±6, 28±10 and 39±9, respectively.
The difference between maximum and minimum mean response (δ)
was 20, whichmeans that a change in the amount of particles had a big-
ger impact on grittiness perception than a change in particle size (δ=
16), within the ranges studied.
3.3.3. Effect of media viscosity on oral grittiness perception
Increasing the viscosity of the oral vehicle was shown to reduce the
grittiness VAS score of the samples. Samples dispersed in the vehicle of
lowest viscosity (0.08 Pas) scored an average grittiness VAS score of
32 ± 13, when dispersed in the vehicle of intermediate viscosity
(0.43 Pas) the average scorewas 28±11, andwhen dispersed in the ve-
hicle of highest viscosity (2.80 Pas) the average score was 26 ± 10.
Within the ranges studied, the impact of media viscosity on grittiness
perception (δ=− 6) was smaller than that of the amount of particles
and their size. Nevertheless, the effect of media viscosity on grittiness
perception was signiﬁcant. This suggests that soft food (i.e. “thick”
ﬂuid) would be more effective than a drink (i.e. “thin” ﬂuid) in terms
of “masking” the presence of particles in the sample.
3.3.4. Interaction between factors and modelling of grittiness perception
Amultiple linear regression analysiswas applied to ﬁt full polynomi-
al equations with added interaction between factors (amount of parti-
cles, particle size and HPMC concentration). All possible interactions
between factorswere not signiﬁcant (p N 0.05), thus themodelwas sim-
pliﬁed through a stepwise process to a ﬁrst order polynomial equation:
Y ¼ β0þβ1X1þβ2X2þβ3X3 þ ε
where X1, X2 and X3 represent the three factors evaluated and β1− β3
their coefﬁcients, with β0 representing the intercept. Statistical analysis
showed signiﬁcant p-values (p b 0.01) for all the studied factors and in-
signiﬁcant lack ofﬁt for themeasured response (p N 0.05), indicating ad-
equate model ﬁt.
The ﬁtted model was employed to generate contour plots via inter-
polation of data within the design space. Individual contour plots of
VAS score vs. amount of particles and particles size are depicted in Fig.
5 for each level of HPMC concentration. Contour plots allow a visual in-
terpretation of results. As shown in the graphs, relatively large amounts
of particles up to 1 g can be better tolerated if particles are small and dis-
persed in a high viscosity vehicle tomask the presence of particles. Sim-
ilarly, particles larger than 200 μm could be better tolerated when given
at a low concentration and dispersed in a vehicle of high viscosity. How-
ever, a simultaneous increase of particle size and amount of particles re-
sults in a signiﬁcant increase of grittiness perception, particularly in
vehicles of lower viscosity.
3.3.5. Participants' preferences in relation to oral grittiness
After testing the corresponding number of samples during each of
the two sessions of the study, participants were asked to select the
two “most pleasant” samples among those tested in that particularsession. This served as a method to evaluate participants' preferences
towards different formulations of multiparticulates. A list of the most
preferred formulations (i.e. those more frequently selected as being
“most pleasant”) is shown in Table 2.
Not surprisingly, the most preferred sample was the blinded nega-
tive control which consisted of 10ml of the 0.5% HPMC vehicle contain-
ing no particles. In contrast, the blinded positive control containing 1 g
of large particles (605 μm) was not selected by any of the participants.
After the blinded negative control, the most preferred samples were
those containing a low amount of small-sized particles (e.g. F4 and
F1). As a general trend, samples selected as “most pleasant” could be
correlated with lower grittiness VAS score. Indeed, a signiﬁcant associa-
tion was found between grittiness VAS score and sample preference
(Spearman's rho =−0.83).
However, samples dispersed in the vehicle of highest viscosity were
less preferred in spite of being less gritty. Remarkably, none of the top 5
most selected samples were prepared using the vehicle containing 2%
(w/v) HPMC. These results indicate that vehicles of lower viscosity
were preferred over the vehicle thickened to the highest consistency.
Nevertheless, the three administration media were not assessed on its
own (i.e. without particles), therefore the previous hypothesis could
not be conﬁrmed. In addition, preference for vehicles containing less
HPMC could be due to an unpleasantmouthfeel of HPMC and not neces-
sarily explained by a change in viscosity.
4. Discussion
MCC spherical granules were used as a model for a multiparticulate
drug delivery system. These inert particles were an ethically sound
model as the participants were not exposed to any drug. The insoluble
particles were dispersed in vehicles of varying viscosity and adminis-
teredwith the aid of a spoon.HPMCwas employed tomodify the viscos-
ity of the suspendingmedia in order tomake it representative of a broad
range of potential vehicles used in practice. HPMC hydrogels showed
shear thinning behaviour, which is commonly seen in food products
and in commercial vehicles for the administration of medicines (Kluk
and Sznitowska, 2014; Selway and Stokes, 2013; Zargaraan et al.,
2013). The rheological properties of HPMC gels prepared at three differ-
ent consistencies account for a variety of potential vehicles ranging from
poorly viscous ﬂuids (≤350 mPas) such as juice to thicker ﬂuids and
soft-food (N1750 mPas) such as yogurt. The oral gels were sweetened
and ﬂavoured to create a more palatable vehicle, which would be
more representative of the proposed real life situation where patients
mix the drug product with food or drinks.
Oral grittiness of multiparticulate formulations was assessed by
healthy adults using a VAS score system. In general terms, grittiness
VAS scores were low; the vast majority of the samples scoring an aver-
age VAS score below 60. The lowVAS score values obtainedwere attrib-
uted to the effect of the sweetened and ﬂavoured vehicles which
improved the feeling of the sample in themouth. The three formulation
factors assessed, viz. particle size, amount of particles and viscosity of
the administration media, were shown to have a signiﬁcant effect on
perception of oral grittiness. Oral grittiness increased with increasing
amount and size of the particles, whereas increasing viscosity of the ad-
ministration media masked perception of grittiness. Within the ranges
studied, the amount of multiparticulates given per sample seemed to
be themost signiﬁcant factor, closely followed byparticle size. The effect
of media viscosity on grittiness perception was moderate compared to
the other two factors, but still signiﬁcant. Furthermore, samples pre-
ferred by the participants of this study (i.e. those selected as being
“most pleasant”) were correlated with a low VAS score for oral
grittiness.
The amount of multiparticulates per sample was a signiﬁcant factor
in the perception of oral grittiness. As expected, samples containing
larger amounts of particles were perceived to be grittier with respect
to samples containing less particles. In practice, the amount of
Fig. 5. Contour plots of VAS score vs particle size and amount of particles, at low (a), medium (b) and high (c) viscosity levels.
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the patient) would be greatly determined by the required therapeutic
dose. The three situations assessed in this study (i.e. 0.25, 0.50 and
1.00 g of particles) aimed to cover a range of different dosing require-
ments,whichmayvary dependingon the drugpotency and the targeted
patient population. Another important determinant of the amount of
multiparticulates per sample would be the maximum drug loading per
particle that can be achieved, which is dependent on themanufacturing
process. The maximum drug loading of multiparticulate formulations is
often low (Gandhi and Baheti, 2013), which means that the amount of
particles required will be relatively high and, in turn, this would be det-
rimental in terms of oral grittiness and overall patient acceptability.
From a formulation development point of view, manufacturing ap-
proaches with a capability for high drug loading should be prioritised
to enable dosing of medicines for pain relief (e.g. ibuprofen) or antibi-
otics (e.g. amoxicillin) (World Health Organisation, 2013).
Particle size was found to be an important determinant of oral grit-
tiness, as demonstrated in previous studies (Engelen et al., 2005; Imai
et al., 1995; Kimura et al., 2015; Mishra et al., 2009). Multiparticulates
of smaller particle size were considered less gritty than larger particlesTable 2
List of samples thatwere selectedmost times as being “most pleasant” in the sensory eval-
uation of multiparticulate preparations by healthy adult participants (n= 30).
ID Amount
(g)
Particle
size
(μm)
HPMC
(%
w/w)
Times ranked “most
pleasant”
Negative
control
– – 0.5 27
F4 0.25 90 1 10
F1 0.25 90 0.5 9
F10 0.25 127 0.5 9
F2 0.50 90 0.5 7and, in turn, samples containing smaller particles were regarded as
more pleasant. In this regard, a reduction of particle size could be a po-
tential strategy to improve palatability of multiparticulate products.
However, a reduction of particle size might also have a major impact
in other characteristics of the formulation, such as drug release. For in-
stance, the release rate from coated granules has been shown to be di-
rectly proportional to the surface area of the coated core granules;
thus, four times more coating solution was needed to maintain the
same drug release rate when particle size was reduced by half
(Ragnarsson and Johansson, 1988). Moreover, the particle size of the
ﬁnal product will increase after ﬁlm coating, with this step needed for
taste masking, controlled release or other purposes. Therefore, the par-
ticle size of multiparticulate formulations must be carefully balanced in
order to achieve the desired quality target product proﬁle, including ap-
propriate palatability and drug release.
The viscosity of the oral vehicle used as a platform for the adminis-
tration of multiparticulates was modiﬁed in order to assess the inﬂu-
ence of media viscosity on the perception of oral grittiness. Samples
suspended in vehicles of thicker consistency received lower values on
the grittiness VAS scoring system than samples suspended in vehicles
of thinner consistency. However, samples prepared with low viscosity
vehicles were often judged to be more pleasant than those prepared
in the thicker vehicles, despite of the increased grittiness perception in
the former. This can be attributed to participants' preferences
concerning the palatability and in particular mouthfeel of the
suspending media. Although thinner vehicles were preferred in this
study, a different situation might be seen in children (who usually con-
sume food products of thicker consistency than adults) and older people
with swallowing difﬁculties who use thickened ﬂuids for nutrition
(O'Leary et al., 2010). Although viscosity was considered to be the pri-
mary parameter that inﬂuences the perception of particles dispersed
in the vehicle other physical properties of the oral vehicles such as stick-
iness, ductility and lubrication capacity can inﬂuence mouthfeel and
162 F.L. Lopez et al. / European Journal of Pharmaceutical Sciences 92 (2016) 156–162palatability and thusmight be important determinants of the overall ac-
ceptability of the product (Batchelor et al., 2015; Kluk and Sznitowska,
2014).
Assessment of palatability and acceptability of oral formulations is a
growing area of interest for formulation scientists. The lack of validated
methodology for the assessment of palatability and acceptability of oral
dosage forms has been highlighted as an important barrier for the de-
velopment of new age-appropriate formulations for paediatric patients
(Venables et al., 2015; Walsh et al., 2014). Current guidance suggests
that, when possible, palatability testing should be conducted using the
ﬁnal formulation and in the targeted population group (European
Medicines Agency, 2013). This study has been conducted in a small pop-
ulation of young adult participants in a controlled setting, using a swirl
and spit methodology. Naive participants took part in the study but
were calibrated with negative and positive controls prior testing. The
actual samples could then be assessed with respect to these references,
and participants became familiar with the tasting protocol and mea-
surement scales. Differences in oral grittiness perception can be expect-
ed with respect to other population groups, such as paediatrics or
geriatrics. Therefore, evaluation of oral grittiness and preferences of
multiparticulate formulations in these patient groups is much needed,
especially as they are the ones that could beneﬁt most from
multiparticulate products.
5. Conclusion
Multiparticulate formulations represent an interesting alternative to
conventional solid dosage forms for the delivery of drugs to patients
with swallowing difﬁculties such as paediatric and geriatric patients.
However, a rough or gritty feeling in the mouth may be perceived
upon oral administration of multiparticulates depending on their size
and amount, limiting palatability and acceptability. This study, in agree-
ment with previous work, suggests that smaller particles would be
more appropriate than larger particles in terms ofmouthfeel and overall
product palatability. However, the data indicated that particles larger
than 200 μm receive low grittiness scores if used at a low concentration
and dispersed in a vehicle of high viscosity. In conclusion, the combined
inﬂuence of particle size and amount of multiparticulates on the per-
ceived grittiness should be reﬂected into formulation optimisation. Fur-
ther consideration should be given to the selection of a suitable vehicle
for oral administration in order to maintain appropriate palatability of
the reconstituted product.
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